Related Experiment Videos
[Anthracycline transport in sensitive and resistant leukemia cells]
R Erttmann1, N Erb, P Forcadell de Dios
1Abteilung für Hämatologie und Onkologie, Universitätskinderklinik, Hamburg.
Klinische Padiatrie
|January 1, 1989
Summary
Anthracycline uptake into leukemic cells is linear with concentration and pH-dependent. Drug resistance in leukemic cells impacts anthracycline accumulation, questioning long-term treatment efficacy.
Area of Science:
- Pharmacology
- Cell Biology
- Oncology
Background:
- Anthracyclines are crucial chemotherapy agents for various cancers.
- Understanding drug uptake mechanisms is vital for optimizing treatment.
- Leukemic cell resistance to anthracyclines necessitates further investigation.
Purpose of the Study:
- To investigate the in-vitro uptake of four anthracyclines into leukemic cells.
- To determine the relationship between drug accumulation and extracellular factors.
- To explore the impact of drug resistance on anthracycline uptake.
Main Methods:
- In-vitro incubation of leukemic cells with four different anthracyclines.
- Measurement of intracellular anthracycline levels.
- Correlation analysis with extracellular drug concentration and pH.
- Comparison of drug uptake in resistant versus wild-type leukemic cell lines.
Main Results:
- Anthracycline accumulation demonstrated a linear correlation with extracellular drug concentration.
- Steady-state intracellular drug levels were rapidly achieved.
- Intracellular drug levels correlated with extracellular pH (6.4-7.4).
- A resistant leukemic subline exhibited significantly restricted anthracycline accumulation.
Conclusions:
- Initial anthracycline uptake is a critical phase in leukemic cells.
- Leukemic cell resistance mechanisms can substantially reduce intracellular drug levels.
- The efficacy of long-term, potentially cardioprotective anthracycline regimens needs evaluation against conventional schedules.